Advasa Holdings, Inc. (ADBT) notified the SEC that it could not complete its Form 10-Q for the quarter ended September 30, 2026, because obtaining and compiling required information was delayed and could not be completed without unreasonable effort and expense. The company expects to file the report on or before November 23, 2026.
Advasa Holdings, Inc. (ADBT) appointed Andre Thompson as an independent non-executive director on November 10, 2026. He joined the Audit, Compensation, and Nominating and Corporate Governance Committees and will chair the Nominating and Corporate Governance Committee.
Under an Independent Director Agreement, he will receive the same compensation payable to the company’s other independent directors, plus additional compensation for the committee chair role. The company said he has no direct or indirect material interest in a transaction requiring disclosure under Item 404(a), and no arrangements or understandings with others led to his selection.
Two Advasa Holdings, Inc. (ADBT) stockholders holding approximately 75% of the voting power approved by written consent an amendment authorizing a reverse stock split, and the board approved the action on October 26, 2026. The board may choose a ratio from 1-for-10 to 1-for-100 and retains discretion over whether and when to implement the split; it may also abandon it. No further stockholder approval is being sought. Advasa had 487,674,534 common shares issued and outstanding as of October 26, 2026.
Nasdaq notified Advasa on October 21, 2026 that its bid price had been below the $1.00 per-share minimum for 30 consecutive business days, giving it until April 19, 2027 to regain compliance. If it does not, Advasa may qualify to transfer to Nasdaq Capital Market; otherwise Nasdaq staff may notify the company that its shares are subject to delisting. The split could take effect no sooner than 20 calendar days after the definitive information statement is mailed. The board expects a higher per-share price but says there is no assurance the split will resolve or maintain compliance with the requirement.
Advasa Holdings, Inc. (ADBT) reports that Managing Director Dongmin Shin’s direct common-stock position was 0 shares on November 3, 2026.
Advasa Holdings, Inc. (ADBT) said Ferdinand Groenewald resigned as a member of its Board of Directors on October 26, 2026, including all committee appointments. The company said his departure was for personal reasons and did not result from disagreements with management or the board about the company’s operations, policies or practices.
Advasa Holdings, Inc. (ADBT) received Nasdaq notice that its common stock had been below the $1.00-per-share minimum bid-price requirement for 30 consecutive business days. Nasdaq provided an initial 180-calendar-day compliance period, until April 19, 2027. Nasdaq staff will confirm compliance if, before that date, the stock meets the applicable standard for at least ten consecutive business days.
If ADBT does not regain compliance by the deadline, it may transfer to the Nasdaq Capital Market if it meets that market’s applicable requirements and notifies Nasdaq of its intent to cure. If it does not qualify for transfer or fails to regain compliance during the period, Nasdaq staff will notify the company that its common stock will be subject to delisting, and the company would be entitled to appeal. The notice has no immediate effect on listing or trading; ADBT common stock continues to trade on the Nasdaq Global Market.
Advasa Holdings, Inc. (ADBT) said its largest stockholder, Mr. Asamitsu Kosugi, intends to surrender 97,413,140 shares for no consideration, representing approximately 20% of the company’s total outstanding common stock. If completed, those shares will cease to be outstanding, reducing outstanding common stock by approximately 20%, assuming no other changes in the number of outstanding shares.
The proposed forfeiture and cancellation have not been completed. Completion remains subject to finalization of required documentation, any necessary corporate approvals, and completion of applicable transfer agent procedures.
Advasa Holdings, Inc. (ADBT) said its Board adopted a dividend policy targeting an annual cash dividend payout ratio of 50% for common stock, beginning with the fiscal year ending March 31, 2027. The ratio compares cash dividends attributable to a fiscal year with consolidated net income attributable to stockholders of common stock for that year, determined under U.S. GAAP after deductions for noncontrolling interests, preferred stock dividends and other required allocations.
The target does not apply when that earnings measure is zero or negative. Any dividend declaration, amount, timing and payment remain subject to separate Board approval and applicable legal, charter, preferred-stock and contractual restrictions. The policy does not obligate the company to pay dividends, and the Board may modify, suspend or discontinue it. No dividend was declared with the announcement.
Advasa Holdings, Inc. (ADBT) announced five-year consolidated operating goals for the fiscal years ending March 31, 2027 through March 31, 2031. For fiscal 2027, targets are USD 18.99 million in consolidated revenue and USD 1.90 million in consolidated operating income; for fiscal 2028, USD 37.97 million and USD 5.70 million; for fiscal 2029, USD 113.92 million and USD 22.78 million; for fiscal 2030, USD 316.46 million and USD 94.94 million; and for fiscal 2031, USD 632.91 million and USD 189.87 million, respectively.
The goals cover the company and its consolidated subsidiaries, and each figure is a full-year target. Management states that the targets are not guarantees of future performance; achieving them depends on factors including customer deployments and commercialization, transaction or sales volumes, realized pricing, operating costs, investments and access to funding. Later-year targets are subject to greater uncertainty.
Advasa Holdings, Inc. (ADBT) appointed William Witherspoon as Chief Financial Officer under an employment agreement effective October 6, 2026. CEO Grady Ryther, who had been serving as interim CFO after Katharyn Field’s departure on August 27, 2026, will step down from that interim role. Witherspoon will remain on the Board as a non-independent director and leave its Audit, Compensation, and Nominating and Corporate Governance Committees.
The agreement provides an annual base salary of $200,000, with eligibility for discretionary bonuses and grants of company equity determined by the Board or authorized compensation committee. It also provides for specified fringe benefits and reimbursement of reasonable and necessary business, entertainment, and travel expenses under company policy. The agreement is at will; either party may terminate it at any time, and Witherspoon must give at least 30 days’ prior written notice if resigning.